Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 18 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 9682925

    Cyclopropaneamine compound

    Takeda Pharmaceutical Company Limited · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  2. US 9676869

    Conjugated anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  3. US 9675597

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  4. US 9670229

    5-HT3 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  5. US 9662316

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 30, 2017 · Expires May 25, 2037

    granted
  6. US 9663514

    Substituted 6-aza-isoindolin-1-one derivatives

    Takeda Pharmaceutical Company Limited · Granted May 30, 2017 · Expires May 25, 2037

    granted
  7. US 9655900

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 23, 2017 · Expires May 18, 2037

    granted
  8. US 9655881

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 23, 2017 · Expires May 18, 2037

    granted
  9. US 9650343

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 16, 2017 · Expires May 11, 2037

    granted
  10. US 9643967

    Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 9, 2017 · Expires May 4, 2037

    granted
  11. US 9643957

    Heterocyclic compounds having cholesterol 24-hydroxylase activity

    Takeda Pharmaceutical Company Limited · Granted May 9, 2017 · Expires May 4, 2037

    granted
  12. US 9637483

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  13. US 9630924

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  14. US 9624170

    4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  15. US 9624184

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  16. US 9617303

    Sustained-release composition and method for producing the same

    Takeda Pharmaceutical Company Limited · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted
  17. US 9611244

    Cyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  18. US 9605000

    Spiro azetidine isoxazole derivatives and their use as SSTR antagonists

    Takeda Pharmaceutical Company Limited · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  19. US 9598398

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  20. US 9598424

    Heteroarylamide inhibitors of TBK1

    Takeda Pharmaceutical Company Limited · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  21. US 9586930

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  22. US 9579407

    Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals

    Takeda Pharmaceutical Company Limited · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  23. US 9573903

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted
  24. US 9562020

    Dihydroxy aromatic heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted